To investigate the predictive ability of baseline serum GPC-3 levels for HCC development, patients were stratified according to serum GPC-3 levels > 55 pg/mL, corresponding to the upper reference limit derived from measurements in 243 healthy blood donors [23]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.